| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA transmembrane transporter activity | 1.07e-04 | 3 | 120 | 2 | GO:0051033 | |
| GeneOntologyMolecularFunction | nucleic acid transmembrane transporter activity | 1.07e-04 | 3 | 120 | 2 | GO:0051032 | |
| GeneOntologyMolecularFunction | (1->3)-beta-D-glucan binding | 2.13e-04 | 4 | 120 | 2 | GO:0001872 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | KIF18A ATP7A RNF213 KIF20B ATP2C1 EIF4A1 EIF4A2 MCM9 DDX11L8 TDRD12 | 3.33e-04 | 441 | 120 | 10 | GO:0016887 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | SPATA7 KIF18A PDCD6IP SPC25 HAUS2 CEP63 CCDC88C CCDC88A SSX2IP ASPM TNKS UVRAG TRIM37 HYDIN CFAP46 | 2.56e-05 | 720 | 123 | 15 | GO:0000226 |
| GeneOntologyBiologicalProcess | cell communication involved in cardiac conduction | 2.69e-05 | 59 | 123 | 5 | GO:0086065 | |
| GeneOntologyBiologicalProcess | cell-cell signaling involved in cardiac conduction | 4.86e-05 | 34 | 123 | 4 | GO:0086019 | |
| GeneOntologyBiologicalProcess | RNA transport | 8.72e-05 | 175 | 123 | 7 | GO:0050658 | |
| GeneOntologyBiologicalProcess | nucleic acid transport | 8.72e-05 | 175 | 123 | 7 | GO:0050657 | |
| GeneOntologyBiologicalProcess | establishment of RNA localization | 9.70e-05 | 178 | 123 | 7 | GO:0051236 | |
| GeneOntologyBiologicalProcess | protein localization to nuclear inner membrane | 1.05e-04 | 3 | 123 | 2 | GO:0036228 | |
| GeneOntologyBiologicalProcess | regulation of SA node cell action potential | 1.05e-04 | 3 | 123 | 2 | GO:0098907 | |
| GeneOntologyBiologicalProcess | B cell adhesion | 1.05e-04 | 3 | 123 | 2 | GO:0097323 | |
| GeneOntologyBiologicalProcess | peptide antigen transport | 1.05e-04 | 3 | 123 | 2 | GO:0046968 | |
| GeneOntologyBiologicalProcess | magnesium ion homeostasis | 1.32e-04 | 17 | 123 | 3 | GO:0010960 | |
| GeneOntologyBiologicalProcess | maintenance of location | 1.33e-04 | 396 | 123 | 10 | GO:0051235 | |
| GeneOntologyBiologicalProcess | maintenance of location in cell | 1.65e-04 | 259 | 123 | 8 | GO:0051651 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 1.74e-04 | 87 | 123 | 5 | GO:0086001 | |
| GeneOntologyBiologicalProcess | microtubule-based process | SPATA7 KIF18A PDCD6IP SPC25 HAUS2 KIF20B CEP63 CCDC88C LRPPRC CCDC88A SSX2IP ASPM TNKS UVRAG TRIM37 HYDIN CFAP46 | 1.81e-04 | 1058 | 123 | 17 | GO:0007017 |
| GeneOntologyBiologicalProcess | detection of yeast | 2.10e-04 | 4 | 123 | 2 | GO:0001879 | |
| GeneOntologyBiologicalProcess | RNA localization | 3.28e-04 | 217 | 123 | 7 | GO:0006403 | |
| GeneOntologyBiologicalProcess | cardiac conduction | 3.33e-04 | 100 | 123 | 5 | GO:0061337 | |
| GeneOntologyBiologicalProcess | positive regulation of the force of heart contraction | 3.49e-04 | 5 | 123 | 2 | GO:0098735 | |
| GeneOntologyBiologicalProcess | detection of fungus | 3.49e-04 | 5 | 123 | 2 | GO:0016046 | |
| GeneOntologyBiologicalProcess | spindle organization | 3.97e-04 | 224 | 123 | 7 | GO:0007051 | |
| GeneOntologyCellularComponent | centrosome | KIF18A RPGRIP1L PDCD6IP HAUS2 KIF20B CEP63 CCDC88C EYS CCDC88A SSX2IP ASPM TNKS CSPP1 UVRAG DDX11L8 PDZD2 TMEM63A | 3.07e-06 | 770 | 124 | 17 | GO:0005813 |
| GeneOntologyCellularComponent | microtubule organizing center | SPATA7 KIF18A RPGRIP1L PDCD6IP HAUS2 KIF20B CEP63 CCDC88C EYS CCDC88A SSX2IP ASPM TNKS CSPP1 UVRAG DDX11L8 PDZD2 TMEM63A | 8.07e-06 | 919 | 124 | 18 | GO:0005815 |
| MousePheno | poor circulation | 7.48e-06 | 19 | 96 | 4 | MP:0001633 | |
| MousePheno | abnormal heart left ventricle wall morphology | 6.00e-05 | 99 | 96 | 6 | MP:0031533 | |
| MousePheno | hemoperitoneum | 6.60e-05 | 12 | 96 | 3 | MP:0005435 | |
| MousePheno | heart left ventricle hypertrophy | 8.20e-05 | 65 | 96 | 5 | MP:0002625 | |
| MousePheno | abnormal Schwann cell morphology | 1.16e-04 | 37 | 96 | 4 | MP:0001106 | |
| MousePheno | abnormal PNS glial cell morphology | 1.16e-04 | 37 | 96 | 4 | MP:0001105 | |
| MousePheno | abnormal myocardium layer morphology | NRG1 NEBL SHC1 LAMA4 RYR2 TBX18 SLC8A1 PKP2 VAV3 UVRAG TRIM37 | 1.24e-04 | 414 | 96 | 11 | MP:0005329 |
| MousePheno | irregular heartbeat | 1.25e-04 | 71 | 96 | 5 | MP:0001636 | |
| MousePheno | abnormal cardiac muscle tissue morphology | NRG1 NEBL SHC1 LAMA4 RYR2 TBX18 SLC8A1 AP2B1 PKP2 VAV3 UVRAG TRIM37 | 1.27e-04 | 489 | 96 | 12 | MP:0010630 |
| MousePheno | enlarged pericardium | 1.29e-04 | 38 | 96 | 4 | MP:0000291 | |
| MousePheno | abnormal heart layer morphology | NRG1 NEBL SHC1 LAMA4 RYR2 TBX18 SLC8A1 PKP2 VAV3 UVRAG TRIM37 | 1.46e-04 | 422 | 96 | 11 | MP:0010545 |
| MousePheno | abnormal trabecula carnea morphology | 1.95e-04 | 78 | 96 | 5 | MP:0004067 | |
| MousePheno | abnormal heart ventricle wall morphology | 1.96e-04 | 296 | 96 | 9 | MP:0031532 | |
| MousePheno | impaired muscle contractility | 2.01e-04 | 297 | 96 | 9 | MP:0000738 | |
| MousePheno | trabecula carnea hypoplasia | 2.73e-04 | 46 | 96 | 4 | MP:0000295 | |
| MousePheno | small gonad | KLHL6 KIF18A IQCH PDCD6IP PGBD1 LAMA2 CEP63 CCDC88C RAD51AP2 KISS1R TET1 MCM9 ASPM GIGYF2 TRIM37 TDRD12 | 3.22e-04 | 885 | 96 | 16 | MP:0001116 |
| MousePheno | abnormal intracellular organelle morphology | SHC1 TRIP11 KIF20B RYR2 CEP63 SLC8A1 SIDT2 ATP2C1 MCM9 PKP2 UVRAG DDX11L8 | 3.51e-04 | 546 | 96 | 12 | MP:0014239 |
| MousePheno | abnormal testis morphology | KLHL6 KIF18A ASB17 RPGRIP1L IQCH PDCD6IP PGBD1 LAMA2 CEP63 CCDC88C RAD51AP2 KISS1R MCM9 ASPM PLXNA4 GIGYF2 TRIM37 TDRD12 | 3.57e-04 | 1081 | 96 | 18 | MP:0001146 |
| MousePheno | abnormal platelet cell number | TRPM7 SIRPB1 NSUN5 SIDT2 KISS1R USP38 ASPM SNRNP40 TNKS IL6ST | 3.91e-04 | 397 | 96 | 10 | MP:0011898 |
| MousePheno | abnormal primary sex determination | KLHL6 KIF18A IQCH PDCD6IP PGBD1 LAMA2 CEP63 CCDC88C RAD51AP2 KISS1R TET1 MCM9 ASPM GIGYF2 TRIM37 TDRD12 | 3.93e-04 | 901 | 96 | 16 | MP:0002211 |
| MousePheno | abnormal male reproductive gland morphology | KLHL6 KIF18A ASB17 RPGRIP1L IQCH PDCD6IP PGBD1 LAMA2 CD209 CEP63 CCDC88C RAD51AP2 KISS1R CCDC62 MCM9 ASPM PLXNA4 GIGYF2 TRIM37 TDRD12 | 4.08e-04 | 1290 | 96 | 20 | MP:0013325 |
| MousePheno | decreased magnesium level | 4.40e-04 | 22 | 96 | 3 | MP:0031658 | |
| MousePheno | decreased circulating magnesium level | 4.40e-04 | 22 | 96 | 3 | MP:0010093 | |
| MousePheno | abnormal brain ependyma motile cilium location or orientation | 4.60e-04 | 5 | 96 | 2 | MP:0030963 | |
| MousePheno | abnormal axon radial sorting | 4.60e-04 | 5 | 96 | 2 | MP:0020452 | |
| MousePheno | abnormal fetal cardiomyocyte mitochondrial morphology | 4.60e-04 | 5 | 96 | 2 | MP:0031607 | |
| MousePheno | small testis | KLHL6 KIF18A IQCH PDCD6IP PGBD1 LAMA2 CEP63 CCDC88C RAD51AP2 KISS1R MCM9 ASPM GIGYF2 TRIM37 TDRD12 | 4.65e-04 | 823 | 96 | 15 | MP:0001147 |
| MousePheno | abnormal myocardial trabeculae morphology | 4.66e-04 | 144 | 96 | 6 | MP:0002189 | |
| MousePheno | abnormal testis size | KLHL6 KIF18A IQCH PDCD6IP PGBD1 LAMA2 CEP63 CCDC88C RAD51AP2 KISS1R MCM9 ASPM PLXNA4 GIGYF2 TRIM37 TDRD12 | 4.66e-04 | 915 | 96 | 16 | MP:0004849 |
| MousePheno | decreased oocyte number | 4.89e-04 | 95 | 96 | 5 | MP:0005431 | |
| MousePheno | abnormal oocyte number | 5.13e-04 | 96 | 96 | 5 | MP:0020152 | |
| Domain | EIF4A1/2 | 4.09e-05 | 2 | 120 | 2 | IPR031258 | |
| Domain | SID-1_RNA_chan | 4.09e-05 | 2 | 120 | 2 | PF13965 | |
| Domain | ASH | 4.09e-05 | 2 | 120 | 2 | IPR031549 | |
| Domain | SID1_TM_fam | 4.09e-05 | 2 | 120 | 2 | IPR025958 | |
| Domain | ASH | 4.09e-05 | 2 | 120 | 2 | PF15780 | |
| Domain | MITF_TFEB_C_3_N | 1.22e-04 | 3 | 120 | 2 | PF15951 | |
| Domain | MiT/TFE_N | 1.22e-04 | 3 | 120 | 2 | IPR031867 | |
| Domain | TF_T-box | 1.65e-04 | 17 | 120 | 3 | IPR001699 | |
| Domain | TBOX | 1.65e-04 | 17 | 120 | 3 | SM00425 | |
| Domain | TF_T-box_CS | 1.65e-04 | 17 | 120 | 3 | IPR018186 | |
| Domain | - | 1.65e-04 | 17 | 120 | 3 | 2.60.40.820 | |
| Domain | TBOX_3 | 1.65e-04 | 17 | 120 | 3 | PS50252 | |
| Domain | T-box | 1.65e-04 | 17 | 120 | 3 | PF00907 | |
| Domain | TBOX_1 | 1.65e-04 | 17 | 120 | 3 | PS01283 | |
| Domain | TBOX_2 | 1.65e-04 | 17 | 120 | 3 | PS01264 | |
| Domain | DUF21 | 2.44e-04 | 4 | 120 | 2 | IPR002550 | |
| Domain | TRPM_tetra | 2.44e-04 | 4 | 120 | 2 | PF16519 | |
| Domain | DUF3371 | 2.44e-04 | 4 | 120 | 2 | PF11851 | |
| Domain | TRPM_tetra | 2.44e-04 | 4 | 120 | 2 | IPR032415 | |
| Domain | MiT/TFE_C | 2.44e-04 | 4 | 120 | 2 | IPR021802 | |
| Domain | DUF21 | 2.44e-04 | 4 | 120 | 2 | PF01595 | |
| Domain | Laminin_domII | 4.04e-04 | 5 | 120 | 2 | IPR010307 | |
| Domain | Musac_Ach_rcpt | 4.04e-04 | 5 | 120 | 2 | IPR000995 | |
| Domain | Laminin_aI | 4.04e-04 | 5 | 120 | 2 | IPR009254 | |
| Domain | Laminin_I | 4.04e-04 | 5 | 120 | 2 | PF06008 | |
| Domain | Laminin_II | 4.04e-04 | 5 | 120 | 2 | PF06009 | |
| Domain | - | 5.82e-04 | 222 | 120 | 7 | 1.25.10.10 | |
| Domain | Alpha_kinase | 6.04e-04 | 6 | 120 | 2 | PF02816 | |
| Domain | MHCK_EF2_kinase | 6.04e-04 | 6 | 120 | 2 | IPR004166 | |
| Domain | HOOK | 6.04e-04 | 6 | 120 | 2 | PF05622 | |
| Domain | ALPHA_KINASE | 6.04e-04 | 6 | 120 | 2 | PS51158 | |
| Domain | Alpha_kinase | 6.04e-04 | 6 | 120 | 2 | SM00811 | |
| Domain | Hook-related_fam | 6.04e-04 | 6 | 120 | 2 | IPR008636 | |
| Domain | CAMSAP_CH | 8.42e-04 | 7 | 120 | 2 | PF11971 | |
| Domain | CAMSAP_CH | 8.42e-04 | 7 | 120 | 2 | IPR022613 | |
| Domain | Prefoldin | 1.19e-03 | 72 | 120 | 4 | IPR009053 | |
| Domain | ARM-like | 1.81e-03 | 270 | 120 | 7 | IPR011989 | |
| Domain | LAM_G_DOMAIN | 1.85e-03 | 38 | 120 | 3 | PS50025 | |
| Domain | ARM | 2.15e-03 | 40 | 120 | 3 | SM00185 | |
| Domain | Laminin_G_2 | 2.15e-03 | 40 | 120 | 3 | PF02210 | |
| Domain | Laminin_G_1 | 2.17e-03 | 11 | 120 | 2 | PF00054 | |
| Domain | LamG | 2.83e-03 | 44 | 120 | 3 | SM00282 | |
| Domain | Armadillo | 3.41e-03 | 47 | 120 | 3 | IPR000225 | |
| Domain | IBN_N | 4.63e-03 | 16 | 120 | 2 | SM00913 | |
| Domain | p53-like_TF_DNA-bd | 4.80e-03 | 53 | 120 | 3 | IPR008967 | |
| Domain | Importin-beta_N | 5.23e-03 | 17 | 120 | 2 | IPR001494 | |
| Domain | - | 5.37e-03 | 109 | 120 | 4 | 4.10.280.10 | |
| Domain | HLH | 5.72e-03 | 111 | 120 | 4 | PF00010 | |
| Domain | Laminin_G | 6.17e-03 | 58 | 120 | 3 | IPR001791 | |
| Domain | ARM-type_fold | 6.32e-03 | 339 | 120 | 7 | IPR016024 | |
| Pathway | BIOCARTA_IRES_PATHWAY | 5.66e-06 | 6 | 94 | 3 | MM1550 | |
| Pathway | BIOCARTA_IRES_PATHWAY | 9.86e-06 | 7 | 94 | 3 | M22028 | |
| Pathway | KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC | 1.33e-04 | 74 | 94 | 5 | M16376 | |
| Pathway | WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY | 1.33e-04 | 74 | 94 | 5 | M39462 | |
| Pathway | BIOCARTA_EIF_PATHWAY | 1.51e-04 | 16 | 94 | 3 | M7721 | |
| Pubmed | 1.15e-08 | 169 | 125 | 9 | 31462741 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | TNPO1 KRT4 PDCD6IP DSC1 SPTBN2 KIF20B GFPT1 WTAP NUP54 NSUN5 LRPPRC PTPN14 NUP155 AP2B1 EIF4A1 SNRNP40 PKP2 ZFR EIF3A TARS1 | 2.42e-08 | 1257 | 125 | 20 | 36526897 |
| Pubmed | SPATA7 RPGRIP1L ATP7A PDCD6IP TRPM7 RNF213 FAM171B TRIP11 RYR2 CCDC88A NUP155 PKP2 ZFR MGA TARS1 | 1.41e-07 | 777 | 125 | 15 | 35844135 | |
| Pubmed | SPTBN2 RNF213 WDFY4 CCDC88C ATP2C1 SSX2IP UBR3 EIF3A PLCH1 MGA TMEM63A PDZRN4 | 2.39e-07 | 493 | 125 | 12 | 15368895 | |
| Pubmed | TLK2 PDCD6IP SPTBN2 SIRPB1 TRIP11 CCDC88C LRPPRC CCDC88A AP2B1 EIF4A1 EIF4A2 DZIP3 GIGYF2 ZFR TNKS MGA | 3.93e-07 | 963 | 125 | 16 | 28671696 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | PDCD6IP DSC1 HIP1R KIF20B GFPT1 NSUN5 LRPPRC PTPN14 NUP155 AP2B1 EIF4A1 ASPM SNRNP40 PKP2 ZFR EIF3A MGA TARS1 | 1.73e-06 | 1353 | 125 | 18 | 29467282 |
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | TNPO1 PDCD6IP GFPT1 LRPPRC NUP155 AP2B1 SNRNP40 GIGYF2 ZFR EIF3A FGG TARS1 | 2.11e-06 | 607 | 125 | 12 | 39147351 |
| Pubmed | Cyclin M2 (CNNM2) knockout mice show mild hypomagnesaemia and developmental defects. | 2.50e-06 | 8 | 125 | 3 | 33859252 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | PDCD6IP TRPM7 TRIP11 CCDC88C LRPPRC PTPN14 CCDC88A TET1 SSX2IP PKP2 GIGYF2 PLCH1 CSPP1 UVRAG | 2.83e-06 | 861 | 125 | 14 | 36931259 |
| Pubmed | 3.74e-06 | 251 | 125 | 8 | 29778605 | ||
| Pubmed | 3.75e-06 | 9 | 125 | 3 | 25488665 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | TLK2 PDCD6IP SPC25 PCMTD1 HAUS2 CEP63 RMI1 NUP155 AP2B1 EIF4A1 EIF4A2 CIZ1 ASPM SNRNP40 ZFR EIF3A | 4.13e-06 | 1155 | 125 | 16 | 20360068 |
| Pubmed | KRT4 PDCD6IP DSC1 GFPT1 LRPPRC NUP155 DZIP3 EIF3A UVRAG TARS1 | 4.34e-06 | 437 | 125 | 10 | 20562859 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | TNPO1 PDCD6IP SPTBN2 NUP54 LRPPRC NUP155 EIF4A1 CIZ1 SNRNP40 GIGYF2 NOL7 ZFR EIF3A MGA TARS1 | 4.34e-06 | 1024 | 125 | 15 | 24711643 |
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 4.99e-06 | 120 | 125 | 6 | 31413325 | |
| Pubmed | Integrin-laminin interactions controlling neurite outgrowth from adult DRG neurons in vitro. | 5.34e-06 | 10 | 125 | 3 | 18590826 | |
| Pubmed | KLHL6 TRPM6 TNPO1 TLK2 PDCD6IP DHDDS FAM171B WDFY4 CEP63 EIF4A2 TET1 DZIP3 MGA TRIM37 UBE2Q2 | 8.57e-06 | 1084 | 125 | 15 | 11544199 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | TNPO1 NRG1 PDCD6IP SHC1 HIP1R NSUN5 NUP155 XPO5 EIF4A1 EIF4A2 SNRNP40 | 8.71e-06 | 582 | 125 | 11 | 20467437 |
| Pubmed | 9.74e-06 | 12 | 125 | 3 | 11381080 | ||
| Pubmed | Expression of laminin receptors in schwann cell differentiation: evidence for distinct roles. | 9.74e-06 | 12 | 125 | 3 | 12843252 | |
| Pubmed | TNPO1 ATP7A PDCD6IP GFPT1 LRPPRC CCDC88A NUP155 XPO5 PKP2 GIGYF2 PLCH1 TARS1 | 1.00e-05 | 708 | 125 | 12 | 39231216 | |
| Pubmed | PDCD6IP SPTBN2 LAMA4 NUP54 CCDC88A AP2B1 GIGYF2 VAV3 EIF3A MGA | 1.10e-05 | 486 | 125 | 10 | 20936779 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 12351402 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 25870292 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 18981244 | ||
| Pubmed | Functional characterization of homo- and heteromeric channel kinases TRPM6 and TRPM7. | 1.28e-05 | 2 | 125 | 2 | 16636202 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 12137941 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 11581396 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 24858416 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 25818163 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 18550768 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 17876530 | ||
| Pubmed | Translational dysregulation in cancer: eIF4A isoforms and sequence determinants of eIF4A dependence. | 1.28e-05 | 2 | 125 | 2 | 26614665 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 9015395 | ||
| Pubmed | C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans. | 1.28e-05 | 2 | 125 | 2 | 12050398 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 19149903 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 25504222 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 24183720 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 18365021 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 31998663 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 14976260 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 12039954 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 25642836 | ||
| Pubmed | Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR. | 1.28e-05 | 2 | 125 | 2 | 11739956 | |
| Pubmed | Oncogenic MITF dysregulation in clear cell sarcoma: defining the MiT family of human cancers. | 1.28e-05 | 2 | 125 | 2 | 16766266 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 12235238 | ||
| Pubmed | L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus. | 1.28e-05 | 2 | 125 | 2 | 15371595 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 26025056 | ||
| Pubmed | Autonomous tetramerization domains in the glycan-binding receptors DC-SIGN and DC-SIGNR. | 1.28e-05 | 2 | 125 | 2 | 19249311 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 21191006 | ||
| Pubmed | Mice lacking SIGNR1 have stronger T helper 1 responses to Mycobacterium tuberculosis. | 1.28e-05 | 2 | 125 | 2 | 17224292 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 21602712 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 27859859 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 20203199 | ||
| Pubmed | Widely divergent biochemical properties of the complete set of mouse DC-SIGN-related proteins. | 1.28e-05 | 2 | 125 | 2 | 16682406 | |
| Pubmed | A novel family of mammalian transmembrane proteins involved in cholesterol transport. | 1.28e-05 | 2 | 125 | 2 | 28785058 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 12391271 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 14729866 | ||
| Pubmed | DC-SIGN and DC-SIGNR polymorphic variants in Northern Asian Indians. | 1.28e-05 | 2 | 125 | 2 | 19046307 | |
| Pubmed | Generation and pharmacological analysis of M2 and M4 muscarinic receptor knockout mice. | 1.28e-05 | 2 | 125 | 2 | 11392613 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 1518869 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 24434373 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 24807965 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 24807966 | ||
| Pubmed | DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2. | 1.28e-05 | 2 | 125 | 2 | 12609975 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 25692682 | ||
| Pubmed | Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins down regulate both DC-SIGN and DC-SIGNR. | 1.28e-05 | 2 | 125 | 2 | 23460925 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 26447454 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 22338216 | ||
| Pubmed | The TRPM6 kinase domain determines the Mg·ATP sensitivity of TRPM7/M6 heteromeric ion channels. | 1.28e-05 | 2 | 125 | 2 | 24385424 | |
| Pubmed | The polymorphisms in DC-SIGNR affect susceptibility to HIV type 1 infection. | 1.28e-05 | 2 | 125 | 2 | 17530994 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 17715238 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 12874603 | ||
| Pubmed | Determination of DC-SIGN and DC-SIGNR repeat region variations. | 1.28e-05 | 2 | 125 | 2 | 16061998 | |
| Pubmed | Role of DC-SIGN and L-SIGN receptors in HIV-1 vertical transmission. | 1.28e-05 | 2 | 125 | 2 | 21277928 | |
| Pubmed | The channel kinases TRPM6 and TRPM7 are functionally nonredundant. | 1.28e-05 | 2 | 125 | 2 | 16150690 | |
| Pubmed | Muscarinic M2 receptors on peripheral nerve endings: a molecular target of antinociception. | 1.28e-05 | 2 | 125 | 2 | 12045234 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 28821869 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 18301276 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 18675813 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 18171520 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 12502850 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 16365281 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 11384997 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 18458800 | ||
| Pubmed | Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR. | 1.28e-05 | 2 | 125 | 2 | 12634366 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 10688600 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 20217198 | ||
| Pubmed | Extended neck regions stabilize tetramers of the receptors DC-SIGN and DC-SIGNR. | 1.28e-05 | 2 | 125 | 2 | 15509576 | |
| Pubmed | A cellular response linking eIF4AI activity to eIF4AII transcription. | 1.28e-05 | 2 | 125 | 2 | 22589333 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 32265261 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 28220887 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 23238564 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 16134084 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 22902397 | ||
| Pubmed | CSPP is a ciliary protein interacting with Nephrocystin 8 and required for cilia formation. | 1.28e-05 | 2 | 125 | 2 | 20519441 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 12223058 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 26079881 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 11880500 | ||
| Pubmed | A dual role for UVRAG in maintaining chromosomal stability independent of autophagy. | 1.28e-05 | 2 | 125 | 2 | 22542840 | |
| Interaction | CEP135 interactions | RPGRIP1L TRPM7 HAUS2 KIF20B CEP63 CCDC88C CCDC88A NUP155 SSX2IP PKP2 CSPP1 | 7.61e-07 | 272 | 121 | 11 | int:CEP135 |
| Interaction | NDC80 interactions | RPGRIP1L TRPM7 SPC25 HIP1R HAUS2 CEP63 XPO5 SSX2IP ASPM DZIP3 CSPP1 | 2.89e-06 | 312 | 121 | 11 | int:NDC80 |
| Interaction | KRT18 interactions | KRT4 RPGRIP1L TRPM7 SHC1 HAUS2 CEP63 XPO5 SSX2IP PKP2 CSPP1 TRIM37 CFAP46 | 8.47e-06 | 419 | 121 | 12 | int:KRT18 |
| Interaction | YWHAZ interactions | TLK2 NRG1 RPGRIP1L DSC1 TRPM7 SPTBN2 HIP1R WTAP TFE3 CCDC88C LRPPRC PTPN14 CCDC88A AP2B1 SSX2IP SNRNP40 PKP2 GIGYF2 EIF3A PLCH1 UVRAG TRIM37 | 1.11e-05 | 1319 | 121 | 22 | int:YWHAZ |
| Interaction | MIB1 interactions | FAM171B CEP63 NUP155 AP2B1 XPO5 SSX2IP GIGYF2 EIF3A MGA CSPP1 | 1.17e-05 | 295 | 121 | 10 | int:MIB1 |
| Interaction | KCNA3 interactions | TNPO1 ATP7A PDCD6IP RNF213 GFPT1 CCDC88C LRPPRC CCDC88A NUP155 XPO5 EIF4A1 CCDC62 PKP2 GIGYF2 PLCH1 TARS1 TDRD12 | 1.77e-05 | 871 | 121 | 17 | int:KCNA3 |
| Interaction | CSPP1 interactions | 2.47e-05 | 96 | 121 | 6 | int:CSPP1 | |
| Interaction | IFT20 interactions | 2.52e-05 | 143 | 121 | 7 | int:IFT20 | |
| Interaction | DUSP28 interactions | 3.53e-05 | 62 | 121 | 5 | int:DUSP28 | |
| Interaction | TNRC6A interactions | TNPO1 RPGRIP1L TRIP11 NUP155 AP2B1 SSX2IP DZIP3 GIGYF2 TRIM37 | 4.93e-05 | 280 | 121 | 9 | int:TNRC6A |
| Interaction | NDEL1 interactions | 6.03e-05 | 164 | 121 | 7 | int:NDEL1 | |
| GeneFamily | T-boxes | 7.78e-05 | 18 | 85 | 3 | 766 | |
| GeneFamily | Cholinergic receptors muscarinic | 2.16e-04 | 5 | 85 | 2 | 180 | |
| GeneFamily | Laminin subunits | 1.40e-03 | 12 | 85 | 2 | 626 | |
| Coexpression | GSE27241_WT_CTRL_VS_DIGOXIN_TREATED_RORGT_KO_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_UP | 1.68e-06 | 172 | 124 | 8 | M8234 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_1000 | KIF18A TRPM7 PCMTD1 SLC8A1 NUP155 DZIP3 UBR3 GIGYF2 VAV3 IL6ST ZNF292 | 7.97e-06 | 375 | 118 | 11 | gudmap_developingKidney_e15.5_cortic collect duct_1000_k4 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | TLK2 SPATA7 KIF18A KIF20B TET1 ASPM DZIP3 GIGYF2 VAV3 EIF3A UBE2Q2 ZNF292 | 1.20e-05 | 469 | 118 | 12 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.75e-05 | 146 | 118 | 7 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500 | 8.55e-05 | 403 | 118 | 10 | gudmap_developingGonad_e12.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.18e-04 | 339 | 118 | 9 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_M-2fold-vs-F_top305_305 | 1.22e-04 | 266 | 118 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_250_M-vs-F-2X | |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.28e-04 | 268 | 118 | 8 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_k1_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | TLK2 ATP7A TRPM7 RNF213 PCMTD1 RYR2 TET1 ASPM DZIP3 GIGYF2 EIF3A MGA CSPP1 TDRD12 | 1.51e-04 | 804 | 118 | 14 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | PDCD6IP NEBL TRPM7 LAMA4 FAM171B PCMTD1 GFPT1 RYR2 TBX18 MCM9 ASPM DZIP3 CSPP1 IL6ST | 1.81e-04 | 818 | 118 | 14 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | TLK2 SPATA7 KIF20B WTAP USP38 TET1 UBR3 EIF3A MGA CSPP1 UBE2Q2 ZNF292 | 2.01e-04 | 629 | 118 | 12 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | TLK2 SPATA7 KIF18A TRPM7 FAM171B PCMTD1 KIF20B CCDC88C CCDC88A SSX2IP ASPM EIF3A PLCH1 CSPP1 TRIM37 ZNF292 | 2.57e-04 | 1060 | 118 | 16 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#2_top-relative-expression-ranked_200 | 3.70e-04 | 61 | 118 | 4 | gudmap_developingGonad_e12.5_epididymis_k2_200 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_top-relative-expression-ranked_1000 | KIF18A PDCD6IP TRPM7 PCMTD1 SLC8A1 NUP155 DZIP3 PKP2 UBR3 GIGYF2 VAV3 IL6ST ZNF292 | 3.72e-04 | 774 | 118 | 13 | gudmap_developingKidney_e15.5_cortic collect duct_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_1000 | 3.79e-04 | 397 | 118 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | TLK2 SPATA7 KIF18A NRG1 KIF20B NUP54 CEP63 CCDC88C CCDC88A GSTCD ASPM PKP2 EIF3A PLCH1 ZNF292 | 3.86e-04 | 989 | 118 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | TBX22 TLK2 SPATA7 RNF213 KIF20B WTAP ATP2C1 USP38 TET1 PKP2 UBR3 EIF3A MGA CSPP1 ZNF292 | 3.86e-04 | 989 | 118 | 15 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_200 | 3.91e-04 | 171 | 118 | 6 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_200 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | TLK2 ATP7A TRPM7 SPC25 FAM171B TET1 ASPM DZIP3 GIGYF2 ZFR EIF3A MGA CSPP1 | 4.52e-04 | 790 | 118 | 13 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | RPGRIP1L RNF213 PCMTD1 CHRM4 RYR2 SIDT2 ETNK2 PLXNA4 PKP2 VAV3 CSPP1 IL6ST ZNF292 | 4.57e-04 | 791 | 118 | 13 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_500 | 4.71e-04 | 409 | 118 | 9 | gudmap_developingGonad_e12.5_ovary_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#5_top-relative-expression-ranked_1000 | 4.72e-04 | 65 | 118 | 4 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k5_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | TLK2 ATP7A TRPM7 RNF213 PCMTD1 RYR2 CCDC62 ASPM DZIP3 GIGYF2 EIF3A MGA CSPP1 | 4.80e-04 | 795 | 118 | 13 | gudmap_developingGonad_e16.5_ovary_1000 |
| CoexpressionAtlas | Myeloid Cells, MF.169+11chi.SLN, CD11b+ CD169+ CD11chigh, Lymph Node, avg-2 | 5.01e-04 | 66 | 118 | 4 | GSM854315_100 | |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | CNNM2 RPGRIP1L RNF213 COL6A5 PCMTD1 CHRM4 RYR2 EIF4A2 ETNK2 PLXNA4 PKP2 CSPP1 IL6ST | 5.27e-04 | 803 | 118 | 13 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | KRT4 LAMA4 FAM171B PCMTD1 HAUS2 GFPT1 ASPM GIGYF2 TNKS EIF3A IL6ST ZNF292 PDZD2 | 5.46e-04 | 806 | 118 | 13 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | TLK2 ATP7A TRPM7 SPC25 RNF213 ETNK2 TET1 ASPM DZIP3 EIF3A MGA CSPP1 TDRD12 | 5.46e-04 | 806 | 118 | 13 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | TLK2 KIF18A NEBL TRPM7 SPTBN2 FAM171B KIF20B WTAP CCDC88C RMI1 CCDC88A GSTCD ASPM ZFR EIF3A PLCH1 CSPP1 TRIM37 | 5.54e-04 | 1370 | 118 | 18 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_1000 | KIF18A PDCD6IP TRPM7 LAMA4 PCMTD1 GFPT1 RYR2 TBX18 MCM9 ASPM DZIP3 GIGYF2 IL6ST | 5.78e-04 | 811 | 118 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_500 | 5.79e-04 | 421 | 118 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_500 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 3.38e-09 | 189 | 125 | 9 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 3.54e-09 | 190 | 125 | 9 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 3.54e-09 | 190 | 125 | 9 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 3.71e-09 | 191 | 125 | 9 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.59e-08 | 168 | 125 | 8 | 52fd65024af8683db11d931f7563cbe8eb815d1c | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-08 | 176 | 125 | 8 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 5.25e-08 | 184 | 125 | 8 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 5.48e-08 | 185 | 125 | 8 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 6.46e-08 | 189 | 125 | 8 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 1.20e-06 | 192 | 125 | 7 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 1.29e-06 | 194 | 125 | 7 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.34e-06 | 195 | 125 | 7 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.62e-06 | 170 | 125 | 6 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 8.62e-06 | 170 | 125 | 6 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L3_THEMIS_PLA2G7|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.21e-06 | 172 | 125 | 6 | 1d086e00cd549459d70e1d3b468d5ab6379f3bee | |
| ToppCell | Control-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations) | 9.84e-06 | 174 | 125 | 6 | 548d7f2b958a2bfd2c95eb049ceaab55a559c77d | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_LINC01474|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.19e-05 | 180 | 125 | 6 | 2ae39e26a8e7d5d4d3e1e71609a8ec36fd9855aa | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.35e-05 | 184 | 125 | 6 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.35e-05 | 184 | 125 | 6 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.39e-05 | 185 | 125 | 6 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.39e-05 | 185 | 125 | 6 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.53e-05 | 188 | 125 | 6 | d7a9fb5b021e127b8d927658a55a71098d513b5c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-05 | 190 | 125 | 6 | 2e88e366d377d74deb53a4ea870973ce5c6532e8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-05 | 190 | 125 | 6 | 0028f886c789ba238c031eae5d96acaed4af8c25 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 1.67e-05 | 191 | 125 | 6 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 1.72e-05 | 192 | 125 | 6 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)-D175|Adult / Lineage, Cell type, age group and donor | 1.72e-05 | 192 | 125 | 6 | 733491e932350e3c216a626cc49c3cd3fe970a82 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.77e-05 | 193 | 125 | 6 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.88e-05 | 195 | 125 | 6 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)|Adult / Lineage, Cell type, age group and donor | 1.88e-05 | 195 | 125 | 6 | 55e25f702af19146a161861cfd15f40bbda1dc35 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.93e-05 | 196 | 125 | 6 | 1522958a92e0126326a9f0d9fb1c5b5c50b001ea | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-05 | 196 | 125 | 6 | 90edf61116ffcb4f8b6be3d0a05732d59b0a87d5 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-05 | 196 | 125 | 6 | c936014125b2ed5f796221b74acb77b8f8359875 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.93e-05 | 196 | 125 | 6 | 1c8294014713684b50885e638668f2ce75f357f0 | |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.99e-05 | 197 | 125 | 6 | e42910a653a1b5bd90c090e9665a84871ed2873f | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.99e-05 | 197 | 125 | 6 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Dendritic_cell-DC_1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.04e-05 | 198 | 125 | 6 | fa5c15a656d4132950092919600e270f1fd79abf | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.04e-05 | 198 | 125 | 6 | d1827e3707b929e3a3562989a0c11537d344e164 | |
| ToppCell | (5)_Dendritic_cell-(52)_cycling_DCs|(5)_Dendritic_cell / shred on Cell_type and subtype | 2.10e-05 | 199 | 125 | 6 | d0ff446a197062b10f37b585f3f8716d6d89e5b7 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Dendritic_cell-DC_1|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.10e-05 | 199 | 125 | 6 | 26ea06960e8ea061a71756750b84489609f78162 | |
| ToppCell | Fetal_29-31_weeks-Immune-alveolar_macrophage_(MARCO_positive)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.10e-05 | 199 | 125 | 6 | 22001aa733273e784051b7f750e07d99aaf7a225 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.16e-05 | 200 | 125 | 6 | ad52b38df5c71f28829b04cd0e6b97f0f9f7610a | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.16e-05 | 200 | 125 | 6 | 2f5b71e55c2de0e77fdae6667eb57f333acc6cd1 | |
| ToppCell | LV-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 3.31e-05 | 130 | 125 | 5 | a3e12984fb61311e49cc76c59f74f4dffc48faa1 | |
| ToppCell | RA-06._Ventricular_Cardiomyocyte_II|RA / Chamber and Cluster_Paper | 3.56e-05 | 132 | 125 | 5 | 82674ec4b0a416e4f08372b86c2a475afe3f38a5 | |
| ToppCell | PBMC-Mild-cDC_2|Mild / Compartment, Disease Groups and Clusters | 3.97e-05 | 135 | 125 | 5 | cb9d834f8301cf53f20e09c3f4cb6a148690196a | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular|TCGA-Stomach / Sample_Type by Project: Shred V9 | 4.41e-05 | 138 | 125 | 5 | 93497c0a5d5e54006653b2dedc7a7041e1a613e6 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.55e-05 | 150 | 125 | 5 | 53de595376a9fc92491dfd58ff25938b0bf79903 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.55e-05 | 150 | 125 | 5 | e4b40b3243ed26d0c46bf196ac06e148834e7ed2 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.65e-05 | 155 | 125 | 5 | 8fdda4e3657ac56188ae88ed3caf145f4d9d1567 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.88e-05 | 160 | 125 | 5 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.88e-05 | 160 | 125 | 5 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_low-phase|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-04 | 166 | 125 | 5 | 43f84d3cd58e93ce00c241656c4cba27604b4932 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC1-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.06e-04 | 166 | 125 | 5 | c8a7d94ed762e5e045ab5f74eef691ddc5f74993 | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.09e-04 | 167 | 125 | 5 | 5c82d801e3b7d7c6c967a73b94b2ee2a8da1fd6e | |
| ToppCell | PND14-Immune-Immune_Myeloid-Dendritic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.12e-04 | 168 | 125 | 5 | 9b8a74abb83c64f0b5829dcb4275f722c82b45dc | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-cDC2-cDC2_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.12e-04 | 168 | 125 | 5 | b7cd33f5da4f37b9384fc3bd3ca01fbc790accfc | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_proliferating_1|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.12e-04 | 168 | 125 | 5 | 2082b15fc7935a211f1c61506b305af5501a21ad | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.12e-04 | 168 | 125 | 5 | 9a8709d34865cfa668d8f3335dc34fc86fc32482 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Dendritic-cDC1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.12e-04 | 168 | 125 | 5 | 4b152b8d0f4a66faf664dfacb7914b18d60ce64a | |
| ToppCell | PND14-Immune-Immune_Myeloid-Dendritic-cDC1-cDC1_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.12e-04 | 168 | 125 | 5 | c3169ad8f4130ef18777ed86770bb722ffb5db85 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.15e-04 | 169 | 125 | 5 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | Control-T/NK_proliferative|World / Disease group and Cell class | 1.15e-04 | 169 | 125 | 5 | fca735cbb55fce4d32dc6632a39acea1d16b87ab | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 169 | 125 | 5 | 5f5bec13208f4c3b6eacbba180c8a6402743b76e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.15e-04 | 169 | 125 | 5 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | droplet-Fat-Bat-18m|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-04 | 170 | 125 | 5 | c720d81bc29a8fd1f1249c6af408471d561f1d5d | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-04 | 170 | 125 | 5 | a78d9789c3e7c84a36e1bd380192d7aba4a4d443 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-04 | 170 | 125 | 5 | ff68600b945b3a5437b14e5411b3db800d0ccbe5 | |
| ToppCell | droplet-Fat-Bat|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-04 | 170 | 125 | 5 | c4ecdfc2b4710da0a5fbb20e9df02536023badb1 | |
| ToppCell | Immune-dendritic_cell|World / Lineage, Cell type, age group and donor | 1.21e-04 | 171 | 125 | 5 | 6a9e2e2d3e1d8cc475bf9765129bc4a32da3b8ea | |
| ToppCell | Pericytes-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.21e-04 | 171 | 125 | 5 | bbc8d9fc83d37c9250345b1e76776610799de9ae | |
| ToppCell | Children_(3_yrs)-Immune-dendritic_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.21e-04 | 171 | 125 | 5 | 6a5ac0f56bd7b4543be103100fb735ca6bc5b8bf | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 172 | 125 | 5 | e495efd25aec60b97ac2b5aa861651bd73174a17 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-5_RORB_CD24|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.32e-04 | 174 | 125 | 5 | 3e29d620b7b4ab1915ddac70ee5a50d09072292b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-04 | 175 | 125 | 5 | 284fdc7a9d303636a637041846850d19d114861a | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-04 | 175 | 125 | 5 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.35e-04 | 175 | 125 | 5 | 8958c5c30437d20a4abd70d7527990f7e2a68b93 | |
| ToppCell | droplet-Lung-18m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.39e-04 | 176 | 125 | 5 | b17317ac41d3215db55a38cbd3366c0947f7a2a3 | |
| ToppCell | COVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.39e-04 | 176 | 125 | 5 | 9df7a124ebafb0087da0cda133a394275d7bed81 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L3_LINC00507_CTXN3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.43e-04 | 177 | 125 | 5 | 96d639407f79669f3990138793d157b94273581c | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.46e-04 | 178 | 125 | 5 | c87945146b2734141f07b39d268e0d8086ee0364 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.46e-04 | 178 | 125 | 5 | ad3de3e03a401dac64431a541899445262246347 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Hematopoietic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.50e-04 | 179 | 125 | 5 | 716856b2c7c660bf5ce00e63efeda6ed121f2baa | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.50e-04 | 179 | 125 | 5 | adf8b025032a03dbb58871a92025cd7efbeb22ff | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.50e-04 | 179 | 125 | 5 | ce95b601bf17ae8167d382a105384b9e65e9407f | |
| ToppCell | LV|World / Chamber and Cluster_Paper | 1.54e-04 | 180 | 125 | 5 | 5ac6f485a58bb29462fec02dfbe8eb70864eafe3 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.58e-04 | 181 | 125 | 5 | af92b8b7f455210dab502ef6964f3a0162180759 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.58e-04 | 181 | 125 | 5 | 6e8c5460021d3999daec58e3d6661a6fa998fd16 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Myeloid|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.58e-04 | 181 | 125 | 5 | 090e89b506d945e123e647d08947e9649a65ce7c | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 181 | 125 | 5 | 3fe648db1cb8326066d8bde3ca1287c5c9af19bd | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.58e-04 | 181 | 125 | 5 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | Healthy_Control-Lymphoid-T-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.58e-04 | 181 | 125 | 5 | ac1ee313910c05b1b3cb497bae14565464919c21 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-04 | 182 | 125 | 5 | 39f9b3eb22293cc27c6e175702c77d1eeb24fdc9 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-04 | 182 | 125 | 5 | 5e1b316599436740f1b30875f0ebd33c3edfb2b6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-04 | 182 | 125 | 5 | 5f513bbb7125956eb528e3120de3fd776770a7c3 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.62e-04 | 182 | 125 | 5 | a3c5c0eff527c8d3848acda14af8f9e99c69b0de | |
| ToppCell | Ciliated_cells-B-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 1.62e-04 | 182 | 125 | 5 | e93968f800bfeb258e4e834fc8bf92d1cb72cd73 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-04 | 183 | 125 | 5 | 738e94b50c4c08c727d4eed0708dda08aa6891b4 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-04 | 183 | 125 | 5 | 2f0ee40e69ad1259e56e8ee4b352736900eb8901 | |
| ToppCell | COVID-19-APC-like-Dendritic_cells|COVID-19 / group, cell type (main and fine annotations) | 1.67e-04 | 183 | 125 | 5 | 703364836b42aa6ac6c68b42b700ac23c4a1afc7 | |
| Drug | Succimer | ATP7A PDCD6IP TRPM7 RNF213 PCMTD1 TRIP11 KIF20B CD209 SLC8A1 PTPN14 CCDC88A DZIP3 UBR3 GIGYF2 ZFR VAV3 EIF3A MGA TRIM37 IL6ST ZNF292 NPAS2 | 6.73e-07 | 1264 | 120 | 22 | ctd:D004113 |
| Drug | Magnetite Nanoparticles | ATP7A PDCD6IP TRPM7 RNF213 PCMTD1 TRIP11 KIF20B CD209 SLC8A1 PTPN14 CCDC88A DZIP3 UBR3 GIGYF2 ZFR VAV3 EIF3A MGA TRIM37 IL6ST ZNF292 NPAS2 | 1.22e-06 | 1310 | 120 | 22 | ctd:D058185 |
| Drug | Butoconazole nitrate [32872-77-1]; Down 200; 8.4uM; HL60; HT_HG-U133A | 8.95e-06 | 194 | 120 | 8 | 2427_DN | |
| Drug | Tranylcypromine hydrochloride [1986-47-6]; Up 200; 23.6uM; PC3; HT_HG-U133A | 9.64e-06 | 196 | 120 | 8 | 2101_UP | |
| Drug | Benzydamine hydrochloride [132-69-4]; Down 200; 11.6uM; PC3; HT_HG-U133A | 1.00e-05 | 197 | 120 | 8 | 5811_DN | |
| Drug | Fludrocortisone acetate [514-36-3]; Down 200; 9.4uM; HL60; HT_HG-U133A | 1.04e-05 | 198 | 120 | 8 | 2368_DN | |
| Drug | Le(x | 1.17e-05 | 9 | 120 | 3 | CID004571095 | |
| Disease | extrapulmonary tuberculosis (is_implicated_in) | 4.91e-05 | 3 | 120 | 2 | DOID:0050598 (is_implicated_in) | |
| Disease | Arrhythmogenic Right Ventricular Dysplasia | 4.91e-05 | 3 | 120 | 2 | C0349788 | |
| Disease | microcephaly (implicated_via_orthology) | 2.98e-04 | 32 | 120 | 3 | DOID:10907 (implicated_via_orthology) | |
| Disease | Cerebral ventriculomegaly | 3.40e-04 | 7 | 120 | 2 | C1531647 | |
| Disease | Hydrocephalus Ex-Vacuo | 3.40e-04 | 7 | 120 | 2 | C0270720 | |
| Disease | Communicating Hydrocephalus | 3.40e-04 | 7 | 120 | 2 | C0009451 | |
| Disease | Fetal Cerebral Ventriculomegaly | 3.40e-04 | 7 | 120 | 2 | C2936718 | |
| Disease | Post-Traumatic Hydrocephalus | 3.40e-04 | 7 | 120 | 2 | C0477432 | |
| Disease | Obstructive Hydrocephalus | 3.40e-04 | 7 | 120 | 2 | C0549423 | |
| Disease | triglyceride measurement, response to selective serotonin reuptake inhibitor | 3.58e-04 | 34 | 120 | 3 | EFO_0004530, EFO_0005658 | |
| Disease | Congenital Hydrocephalus | 4.52e-04 | 8 | 120 | 2 | C0020256 | |
| Disease | Aqueductal Stenosis | 4.52e-04 | 8 | 120 | 2 | C2936786 | |
| Disease | Tremor, Neonatal | 5.80e-04 | 9 | 120 | 2 | C0235843 | |
| Disease | Todd Paralysis | 5.80e-04 | 9 | 120 | 2 | C0234544 | |
| Disease | Tremor, Perioral | 5.80e-04 | 9 | 120 | 2 | C0235078 | |
| Disease | Nerve Tremors | 5.80e-04 | 9 | 120 | 2 | C0235083 | |
| Disease | Tremor, Limb | 5.80e-04 | 9 | 120 | 2 | C0235081 | |
| Disease | Tremor, Muscle | 5.80e-04 | 9 | 120 | 2 | C0235082 | |
| Disease | Senile Tremor | 5.80e-04 | 9 | 120 | 2 | C0149840 | |
| Disease | Paralysed | 5.80e-04 | 9 | 120 | 2 | C0522224 | |
| Disease | Pill Rolling Tremor | 5.80e-04 | 9 | 120 | 2 | C0751564 | |
| Disease | Tremor, Semirhythmic | 5.80e-04 | 9 | 120 | 2 | C0751565 | |
| Disease | Hydrocephalus | 5.80e-04 | 9 | 120 | 2 | C0020255 | |
| Disease | Action Tremor | 5.80e-04 | 9 | 120 | 2 | C0234376 | |
| Disease | Passive Tremor | 5.80e-04 | 9 | 120 | 2 | C0234377 | |
| Disease | Static Tremor | 5.80e-04 | 9 | 120 | 2 | C0234378 | |
| Disease | Resting Tremor | 5.80e-04 | 9 | 120 | 2 | C0234379 | |
| Disease | Intermittent Tremor | 5.80e-04 | 9 | 120 | 2 | C0234372 | |
| Disease | Fine Tremor | 5.80e-04 | 9 | 120 | 2 | C0234373 | |
| Disease | Coarse Tremor | 5.80e-04 | 9 | 120 | 2 | C0234374 | |
| Disease | Massive Tremor | 5.80e-04 | 9 | 120 | 2 | C0234375 | |
| Disease | Persistent Tremor | 5.80e-04 | 9 | 120 | 2 | C0234370 | |
| Disease | Continuous Tremor | 5.80e-04 | 9 | 120 | 2 | C0234371 | |
| Disease | Darkness Tremor | 5.80e-04 | 9 | 120 | 2 | C0234381 | |
| Disease | Involuntary Quiver | 5.80e-04 | 9 | 120 | 2 | C1527384 | |
| Disease | Saturnine Tremor | 5.80e-04 | 9 | 120 | 2 | C0040827 | |
| Disease | arrhythmogenic right ventricular cardiomyopathy (is_implicated_in) | 7.23e-04 | 10 | 120 | 2 | DOID:0050431 (is_implicated_in) | |
| Disease | Tremor | 8.81e-04 | 11 | 120 | 2 | C0040822 | |
| Disease | papillary thyroid carcinoma | 1.05e-03 | 12 | 120 | 2 | EFO_0000641 | |
| Disease | vital capacity | NRG1 IQCH SPTBN2 LAMA2 DHDDS TRIP11 GFPT1 RYR2 TBX18 RMI1 SLC8A1 GSTCD PDZD2 | 1.58e-03 | 1236 | 120 | 13 | EFO_0004312 |
| Disease | pulse pressure measurement | NRG1 CNNM2 IQCH NEBL TRPM7 SPC25 PGBD1 RNF213 CHRM2 TBX18 TET1 UBR3 HYDIN NPAS2 | 1.59e-03 | 1392 | 120 | 14 | EFO_0005763 |
| Disease | Meckel-Gruber syndrome | 1.66e-03 | 15 | 120 | 2 | C0265215 | |
| Disease | lysosomal storage disease (implicated_via_orthology) | 1.90e-03 | 16 | 120 | 2 | DOID:3211 (implicated_via_orthology) | |
| Disease | primary autosomal recessive microcephaly (is_implicated_in) | 1.90e-03 | 16 | 120 | 2 | DOID:0070296 (is_implicated_in) | |
| Disease | Cardiomyopathies | 1.99e-03 | 130 | 120 | 4 | C0878544 | |
| Disease | Seizures | 2.01e-03 | 218 | 120 | 5 | C0036572 | |
| Disease | hypertension, white matter hyperintensity measurement | 2.08e-03 | 62 | 120 | 3 | EFO_0000537, EFO_0005665 | |
| Disease | major depressive disorder (is_marker_for) | 2.14e-03 | 17 | 120 | 2 | DOID:1470 (is_marker_for) | |
| Disease | Moyamoya Disease | 2.14e-03 | 17 | 120 | 2 | C0026654 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 2.14e-03 | 17 | 120 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | Tachycardia | 2.40e-03 | 18 | 120 | 2 | C0039231 | |
| Disease | Meckel syndrome type 1 | 2.40e-03 | 18 | 120 | 2 | C3714506 | |
| Disease | Tachyarrhythmia | 2.40e-03 | 18 | 120 | 2 | C0080203 | |
| Disease | Microcephaly | 2.60e-03 | 67 | 120 | 3 | C0025958 | |
| Disease | familial hyperlipidemia (biomarker_via_orthology) | 2.68e-03 | 19 | 120 | 2 | DOID:1168 (biomarker_via_orthology) | |
| Disease | Cannabis use, age at onset | 2.68e-03 | 19 | 120 | 2 | EFO_0004847, EFO_0007585 | |
| Disease | schizophrenia (implicated_via_orthology) | 2.71e-03 | 68 | 120 | 3 | DOID:5419 (implicated_via_orthology) | |
| Disease | Joubert syndrome 1 | 3.27e-03 | 21 | 120 | 2 | C4551568 | |
| Disease | Schizophrenia | 3.29e-03 | 883 | 120 | 10 | C0036341 | |
| Disease | Retinitis pigmentosa | 3.45e-03 | 74 | 120 | 3 | cv:C0035334 | |
| Disease | Autosomal Recessive Primary Microcephaly | 3.59e-03 | 22 | 120 | 2 | C3711387 | |
| Disease | gamma-glutamylglutamine measurement | 3.59e-03 | 22 | 120 | 2 | EFO_0021138 | |
| Disease | Primary microcephaly | 3.59e-03 | 22 | 120 | 2 | C0431350 | |
| Disease | aspartate aminotransferase measurement | 3.89e-03 | 904 | 120 | 10 | EFO_0004736 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SIKVNRQLQTVNNYF | 56 | P08173 | |
| NNLQVAVKNNIDVFY | 801 | P63010 | |
| SKLQNNNVYTIAKRN | 866 | P63010 | |
| NYINLNAVSNKTLVF | 221 | Q13939 | |
| RQIYVKQQSDLQFLN | 286 | Q6P9F0 | |
| YNKTAAQIVLRFNIQ | 251 | P51857 | |
| QKLQNIIASRATQYN | 181 | Q9Y2D8 | |
| AQQFRKQTQAQVYSE | 2226 | Q8IYW2 | |
| VSIKVNRHLQTVNNY | 46 | P08172 | |
| QSRQDAIYQNLTQLK | 71 | Q9NNX6 | |
| ALKQASVVIQQQYQA | 2356 | Q8IZT6 | |
| SVVIQQQYQANRAAK | 2361 | Q8IZT6 | |
| TLTQQQRDVYQQEKA | 501 | P98194 | |
| DAQISNALNAQQYKV | 1166 | Q04656 | |
| DNTLQLRYNTTQKVF | 486 | Q09MP3 | |
| LIQQKSAVEYAQSQL | 856 | Q6ZMN7 | |
| IIATNTYQQVQQTLE | 86 | Q9BTD8 | |
| FIYSLRNQQVKQAFI | 286 | Q96RD1 | |
| IEKYLNVVNQNVLTT | 61 | Q86VS3 | |
| VQLVNQYVSKNVISS | 306 | Q02297 | |
| QNVKQLYALVCETQR | 31 | Q96P11 | |
| RQVKYAQSQTVFQNP | 701 | Q99743 | |
| KLTFSTTQIQQYENV | 246 | Q7Z5J8 | |
| NTNYAQKFQERVTIT | 76 | A0A0C4DH39 | |
| QQITNIQAEIYQKNL | 51 | Q9NVX0 | |
| KQVQSYIIQNFVQIL | 191 | Q8WZ60 | |
| IQNQTLIKAYINNSL | 3071 | Q5T1H1 | |
| NRLISAKQQLQTQGY | 131 | Q68CZ1 | |
| VTSNHLQAKIINNNY | 826 | Q2M2H8 | |
| VTAYQNIQITQLKID | 236 | Q8IWI9 | |
| SNVLNVNNHITQYVK | 361 | Q8NI77 | |
| QTRQSNIFKILLQYG | 156 | Q8WXJ9 | |
| AEALYQTKVQQLQIS | 326 | P19013 | |
| QNLTILVRNIKTYYQ | 76 | Q9P219 | |
| STNYNQQLRQELKTV | 986 | Q3V6T2 | |
| VQRLYVQVNKFALAS | 326 | Q9NVF9 | |
| IYDIFQKLNSNTQVV | 196 | P60842 | |
| VKQRINTYVFVGNQL | 281 | Q96MG8 | |
| VSVQQSLAAYNQRKA | 361 | Q8WUM4 | |
| ALVSKQVTAYNAVNN | 1596 | Q9HCM2 | |
| FVSEQQQKLSRLQYS | 631 | P26006 | |
| QAAIQKLQEYIQLNF | 36 | O15018 | |
| QEIQKLSNSTAVYFQ | 136 | Q16649 | |
| KQSLQSYQEALQQQI | 626 | Q1MSJ5 | |
| LVTQNNKAEYVQLVT | 731 | Q8IYU2 | |
| NLTLSKEVQQIQSNY | 926 | Q96Q89 | |
| KFVNYIQQVSVQATC | 116 | Q969F8 | |
| QNIVFNAETYSNLIK | 1061 | P42704 | |
| QQVFQIAYVIVKAAN | 131 | P24043 | |
| NNSVYTNVLVQNSLR | 436 | Q32M88 | |
| YTNLQVKTGQRTLIN | 286 | O94886 | |
| NKIAFLRTQYNEQIN | 921 | Q86Y13 | |
| QQKATRVYAVVQISA | 256 | P35410 | |
| ISLQAIQQLVRKSYQ | 776 | O75694 | |
| QKVQSVSQNKSYLAV | 161 | Q9UMY1 | |
| LQKNQTTSVAKIAQY | 361 | Q7Z3B4 | |
| LQEIYNSNNQKIVNL | 136 | P02679 | |
| EAQRYIAQLKSQVNA | 376 | O75146 | |
| YSQTLVFQIAQSAQK | 1796 | Q4G0P3 | |
| HLQNYTVNATKLTVN | 376 | P40189 | |
| YAQVLAQQQKAALSS | 636 | Q6Y7W6 | |
| ITLQELQQATKTVYQ | 421 | P0C221 | |
| QQVSQIYQSIEFSRL | 441 | Q14152 | |
| LIYQQQVSSLEAQRK | 161 | Q96MT8 | |
| QIYQKAVFDSLLQVN | 1261 | A8TX70 | |
| QSQIDNINLFKVQRY | 486 | A8MPP1 | |
| QIYEIFQKLNTSIQV | 196 | Q14240 | |
| KNNQYNISVVAVDAV | 541 | Q08554 | |
| TTQIQYLKQVQQPSV | 91 | Q15007 | |
| LQELIAQAVQATKNY | 131 | Q86SQ9 | |
| QVAKQVFNTLTEYIQ | 3911 | Q92736 | |
| QQLNNLVYVVTNQAK | 426 | Q8NEC7 | |
| KVQVNDIISRQYLSQ | 86 | Q6P995 | |
| QYALRKIQINNAENT | 331 | Q16363 | |
| IVLKANYIQVNNEQS | 261 | Q9NXL9 | |
| KIRNAQLAQYNFILV | 661 | P26639 | |
| YSNAQKTILLQVDQN | 171 | Q9P2Y5 | |
| QTSYIQQINNLKERL | 426 | O94972 | |
| QLVITYQTVVNVTGN | 466 | Q8NBJ9 | |
| TYAKCQNALQQVVAR | 616 | Q06210 | |
| EVVNYVQKRNSQISN | 446 | Q9H9A7 | |
| AIQYFQNLLKATTQV | 156 | Q587J7 | |
| KFVYQVLIQFLQNSR | 1171 | Q15678 | |
| IRKKAAIQTFQNTYQ | 181 | Q96DI7 | |
| PKFVQSRNQQEVIYN | 761 | Q6P9B9 | |
| NYASQKNVSLEVTVQ | 441 | Q96JS3 | |
| IYTLRNQQVKQAFKN | 286 | Q9NZP0 | |
| NQVNVTCQVRKFYPQ | 266 | Q5TFQ8 | |
| FLEYQNQISRQNKLI | 61 | Q9HBM1 | |
| AYNSQVQLTVNANQK | 1281 | Q8NFU7 | |
| YAFQNLIKQQERINS | 316 | Q86UE8 | |
| LVYCLLSQQVQKQYQ | 596 | Q9BY15 | |
| QDAIYQNLTQLKAAV | 86 | Q9H2X3 | |
| LQLQKQVQTQTYPQV | 421 | Q9ULV3 | |
| VQFVKITRQQYQNAL | 776 | Q9NRU3 | |
| DLQFVKISRQQYQNA | 801 | Q9H8M5 | |
| TKNYVALQILQQTFF | 3046 | Q63HN8 | |
| KQFQNVQQVEYSSIR | 4796 | Q63HN8 | |
| AQQSYNSIVQIHEKN | 351 | Q8WVN8 | |
| IQQQRAAQKLIYTFN | 1831 | Q9BX84 | |
| IQQAQRQQVKQYLST | 131 | O75030 | |
| LQQARRQQVKQYLST | 191 | P19532 | |
| TIQSKLRANNQKVYT | 371 | O15020 | |
| ILVIRQEAYKQQNAT | 66 | P0DTU3 | |
| VTAYQNQQITRLKID | 306 | O95935 | |
| FTTVTAYQNQQITKL | 256 | Q9Y458 | |
| QLVITYQTVVNVTGN | 461 | Q9NXL6 | |
| IFNRYNVIRIQKVVN | 1141 | O95271 | |
| YNIQLPSVNTVQNNK | 1791 | O60281 | |
| AISKAQNLSIIQYLQ | 246 | Q6ZS81 | |
| SFLLNTLQENVNKYQ | 191 | Q9HAV4 | |
| SEVTIQQERQQYQKA | 456 | Q9P0W8 | |
| NQVKIYTNQEKTRTF | 156 | Q9BQ65 | |
| YVSQVTKVSNLLQNI | 191 | Q8NB14 | |
| VYQRCVNLVQKTLAQ | 616 | Q92973 | |
| FNNIQDVKTQSISYL | 1421 | Q4KWH8 | |
| YTQAQQTRQVTAIKP | 201 | Q96KR1 | |
| EIQIKQQSTSYRNQL | 86 | Q15643 | |
| QQSTSYRNQLQQKEV | 91 | Q15643 | |
| ALQLSVSQEQVKQYA | 1656 | Q15643 | |
| VSQEQVKQYALSLAN | 1661 | Q15643 | |
| LTQVLTNQQNYKDLT | 266 | Q6ZT12 | |
| ILVIRQEAYKQQNAT | 66 | A0JD32 | |
| YIQNRNIQTDNNKSI | 631 | Q99959 | |
| SYVNVQNLDKARQAV | 426 | P29353 | |
| FNNVYLQVKAISNIV | 1096 | Q96QT4 | |
| RNTQSLIQYQNVETK | 251 | Q96RE9 | |
| ILVIRQEAYKQQNAT | 66 | A0A0B4J264 | |
| IVNKNDQNLYQVFIN | 256 | Q9UKW4 | |
| IELANYQVLSQQQKS | 346 | P32418 | |
| QRIKTTQQNISAVFY | 581 | O76041 |